Editor in Chief, Condensates.com
|Published||November 5, 2021|
Great news for condensates scientists: the latest installment of US federal support for biomolecular condensates (BMCs) was announced last week. The NIH via the National Institute on Aging (NIA) is accepting applications to fund exploratory research on the impact of phase separation on aging and Alzheimer’s disease (AD) or AD-related dementias (ADRD) via R21 grants. The announcement states:
This research should enhance our understanding of the cell-specific mechanistic role of BMCs in aging and AD/ADRD and serve as the foundation for more comprehensive etiological studies that might lead to the development of future BMC-based therapies for age-related neurodegenerative diseases.
The NIA plans to invest $2.5 million in 8-10 awards. This funding opportunity follows another from earlier this year where the NIA teamed up with other institutes to support finding new tools to study condensates.
Applications are due between February 3 and March 3 of 2022 to provide 2 years of funding starting December 2022.
For more information, see the request for applications.